NCT03639181View on ClinicalTrials.gov

Clinical Trial in Chinese Patients of B-cell Non-Hodgkin's Lymphoma(GB226)

PHASE2UnknownINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

October 15, 2018

Primary Completion Date

September 30, 2021

Study Completion Date

December 30, 2022

Conditions
B-cell Non-Hodgkin's Lymphoma
Interventions
BIOLOGICAL

GB226

3mg/kg treat every 2 weeks

Trial Locations (1)

100021

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

Sponsors
All Listed Sponsors
lead

Genor Biopharma Co., Ltd.

INDUSTRY